Business Of Biotech cover image

008: Commitment To GMP With Dr. Shabbir Anik

Business Of Biotech

00:00

The Risks of Using a CDMO in Pharma

One of the concerns and certainly in the early days of pharma always have concerns about using CDMOs because you know, you basically are relying on their abilities to manage all the GMP related functions. You do need to make sure you have good oversight of your CDMO starting early on when you select the CDMO. That you've done your due diligence, both in terms of, you know, their previous history regulatory history,. A QA audit with your own either your own QA people or consultants that you would use. And also ensuring in parallel that there was strong technical groupBecause generally, without that, you can also have a stumble in terms of actually developing and or doing the

Play episode from 20:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app